U.S. equity contracts and European shares are on the rise with oil, rebounding from Friday’s steep decline due to fears of a new virus variant. There are reports that this strain’s symptoms are relatively mild, but the WHO warns of “severe consequences.”
Pfizer's preliminary analysis of its COVID-19 antiviral pill provided very high success rates. Pfizer's CEO has spoken of his company's pill as a "game-changer." Is he right? How might this pill affect the stock prices of Pfizer and its competitors, as well as the broader market?